Table 2 Percentages of fulfilled indices for metabolic syndrome, use of psychotropics, and number of medications among different diagnoses †
From: Metabolic syndrome among psychiatric outpatients with mood and anxiety disorders
Total sample (n = 229) | Bipolar I (n = 15) | Bipolar II (n = 16) | MDD (n = 141) | Only anxiety disorders (n = 36) | No mood and/or anxiety disorders (n = 21) | |
|---|---|---|---|---|---|---|
MetS | 22.3 (51) | 46.7 (7) | 25.0 (4) | 22.0 (31) | 16.7 (6) | 14.3 (3) |
Central obesity | 46.3 (106) | 73.3 (11) | 62.5 (10) | 45.5 (64) | 41.7 (15) | 28.6 (6) |
BMI > 30 kg/m2 | 8.3 (19) | 13.3 (2) | 18.8 (3) | 7.8 (11) | 8.3 (3) | 0 (0) |
Elevated TG | 35.8 (82) | 60.0 (9) | 37.5 (6) | 36.9 (52) | 30.6 (11) | 19.0 (4) |
Reduced HDL | 30.6 (70) | 46.7 (7) | 37.5 (6) | 29.8 (42) | 27.8 (10) | 23.8 (5) |
Elevated BP | 38.4 (88) | 40.0 (6) | 25.0 (4) | 41.1 (58) | 38.9 (14) | 28.6 (6) |
Elevated FPG | 18.3 (42) | 13.3 (2) | 12.5 (2) | 20.6 (29) | 13.9 (5) | 19.0 (4) |
Antipsychotics | 23.1 (53) | 80.0 (12) | 25.0 (4) | 22.7 (32) | 8.3 (3) | 9.5 (2) |
Mood stabilizers | 12.2 (28) | 93.3 (14) | 31.3 (5) | 6.4 (9) | 0 (0) | 0 (0) |
Antipsychotics and/or mood stabilizers | 27.9 (64) | 100.0 (15) | 50.0 (8) | 25.5 (36) | 8.3 (3) | 9.5 (2) |
Antidepressants | 89.5 (205) | 40.0 (6) | 81.3 (13) | 95.7 (135) | 94.4 (34) | 81.0 (17) |
Number of medications | 1.6 ± 0.8 | 2.4 ± 0.9 | 1.7 ± 1.1 | 1.6 ± 0.8 | 1.4 ± 0.6 | 1.1 ± 0.7 |